Alurar rigakafin AstraZeneca da aka dakatar a cikin adadin ƙasashe yana da matukar damuwa.
The AstraZeneca Oxford Vaccine an dakatar da shi a cikin kasashe masu tasowa saboda damuwa da damuwa game da cutar da ke haifar da gudan jini. Kasar Denmark ce kasa ta farko da ta dakatar da amfani da allurar Oxford AstraZeneca a lokacin da rahotanni suka zo cewa wasu mutane na fama da gudan jini kuma mutum daya ya mutu kwanaki 10 bayan karbar alluran guda daya. Sun ce dakatarwar za ta dauki kimanin makonni biyu kuma suna bincike idan jinin ya toshe da kuma allurar AstraZeneca Oxford COVID-19 suna da alaƙa.
Ya kara muni ko da yake:
Daga baya Norway, Bulgaria, Thailand, Iceland, da Kongo duk sun dakatar da amfani da maganin AstraZeneca. Jami'an kiwon lafiya na Norway sun ba da rahoton cewa mutane hudu da suka karɓi maganin suna da ƙarancin adadin platelet na jini da ba a saba gani ba. Abin mamaki, platelet na jini su ne ke taimaka wa gudanwar jini da raguwar adadinsu na iya haifar da zubar jini mai tsanani, wanda ya dan yi karo da juna.
Yawancin kasashen sun bayyana gaskiyar cewa wannan dakatarwar ce ba wai dakatarwa ba kuma suna kan bincike.
Gwamnatin Burtaniya ta ci gaba da matsawa cewa mutane sun sami allurar cikin sauri kuma babu wata shaida da ke nuna rashin lafiya. A Burtaniya, an ba da allurai miliyan 11 na allurar Oxford AstraZeneca kuma ba a tabbatar da kamuwa da cutar daskarewar jini ta hanyar rigakafin coronavirus ba.
Ciwon jini da kansu a hannu ko kafafu ba shi da wata illa musamman, lamarin shi ne idan wadannan gudan guda suka watse suka bi ta cikin jiki suka toshe jini zuwa wata muhimmiyar gabo ko kwakwalwa, wanda hakan kan haifar da bugun zuciya ko bugun jini.
Ya zuwa yanzu ba a tabbatar da ko ɗaya daga cikin lamuran da ke haifar da toshewar jini ta hanyar alaƙar da za a haɗa ta kowace hanya zuwa rigakafin AstraZeneca Oxford. A cikin 'yan sa'o'i na ƙarshe, da Hukumar Kula da Magungunan Turai kwanan nan sun sanar da cewa ga maganin rigakafin Oxford AstraZeneca sun 'dauka sosai' cewa fa'idodin sun fi haɗari. Hukumar ta EMA ta sake nanata cewa adadin jinin da aka samu a cikin mutanen da aka yi wa allurar bai haura fiye da yadda ake gani a yawan jama'a ba.
Jamus ita ce ƙasa ta ƙarshe da ta ba da sanarwar cewa an dakatar da rigakafin AstraZeneca amma ta ce "Shawarar ta yau matakin yin taka tsantsan ce kawai,". Gwamnatin Faransa ma ta bi sahun tana mai cewa an dakatar da rigakafin AstraZeneca har zuwa ranar Alhamis.
Ga hujjoji ya zuwa yanzu:
AstraZeneca da kanta ta fitar da wata sanarwa inda ta ce an samu rahotanni guda 37 na toshewar jini daga cikin mutane miliyan 17 da suka samu rigakafin. Kashi kaɗan mai ban mamaki. Suna da'awar cewa babu kwata-kwata babu wata shaida daga gwajin asibiti na AstraZeneca kuma a cikin yawan jama'a cewa maganin yana ƙara haɗarin guda ɗaya.
The Gwajin rigakafin Oxford AstraZeneca ya kasance mai ban sha'awa, yana tabbatar da kariya 100% daga mummunan alamun COVID-19 tare da kariya sama da 70% bayan kashi na farko. Gwajin asibiti na AstraZeneca ya kuma tabbatar da cewa rigakafin su ya rage yada cututtuka da kashi 67%.
The Illolin rigakafin AstraZeneca suna da laushi, amma suna da yawa musamman bayan kashi na farko, yayin da tare da allurar Pfizer BioNTech, illolin sun fi yawa bayan kashi na biyu. Abubuwan illar rigakafin AstraZeneca sun haɗa da taushi da zafi a wurin allurar, gajiya, ciwon kai, tashin zuciya, sanyi, da gudawa. Waɗannan suna da yawa bayan kashi na farko amma yawanci suna raguwa bayan kwana biyu. Abubuwan da ba a saba gani ba na maganin rigakafin AstraZeneca Oxford suna jin dimi, ciwon ciki, da yawan gumi. Kamar yadda kuke gani ba a lissafta gudan jini.
Don haka ko da yake an dakatar da rigakafin AstraZeneca a cikin ƙasashe masu tasowa, musamman a Turai, yana da alama matakin yin taka tsantsan ne kuma a halin yanzu babu ƙaramin shaida da ke nuna cewa ba shi da aminci. Koyaya, majinyata waɗanda suka san yanayin da suka gabata, musamman jini da masu alaƙa da zuciya, yakamata su yi taka tsantsan.
Ga layin ƙasa:
Kamar yadda yake tare da duk allurar COVID-19, dole ne mu sani cewa wannan sabon alurar riga kafi ne kuma bai sami lokacin da za a gwada shi sosai ba kamar yadda sauran magunguna suka kasance saboda yanayin cutar. Akwai ƙananan bayanai na musamman kan yadda rigakafin ke shafar yara da mutanen da ke da yanayi iri-iri da suka gabata. Hakanan akwai ƙananan bayanai kan yadda zai iya hulɗa tare da ɗimbin adadin magunguna waɗanda ba a gwada su da su ba.
Koyaya, alluran rigakafin suna ceton rayuka kuma wataƙila ita ce kawai hanyar da za mu iya samun ikon COVID-19 kuma akwai ƙarancin shaida cewa alluran suna da illa a yanzu, don haka kada ku damu, tukuna.
Ka tuna zuwa SANTA zuwa gare mu a YouTube kuma ku danna kararrawa ta sanarwar don kada ku rasa wani labari na gaske da ba a tantance ba.
Disclaimer: Babu wani ɓangare na wannan labarin da ya ƙunshi shawarar likita; dole ne ku tuntubi ƙwararrun likita don duk wata damuwa da kuke da ita.
Danna nan don ƙarin labarai masu alaƙa da Burtaniya.
Muna bukatar taimakon ku! Mun kawo muku labaran da ba a tantance ba FREE, amma za mu iya yin wannan kawai godiya ga goyon bayan masu karatu masu aminci kamar haka KA! Idan kun yi imani da 'yancin magana kuma kuna jin daɗin labarai na gaske, da fatan za a yi la'akari da tallafawa aikin mu ta zama majiɓinci ko ta hanyar yin a gudummawar lokaci ɗaya a nan. 20% na ALL ana bayar da kudade ga tsoffin sojoji!
Wannan labarin yana yiwuwa ne kawai godiya ga mu masu tallafawa da majiɓinta!
By Richard Ahern - MediaLine Media
Contact: Richard@lifeline.news
References
1) Maganin Oxford/AstraZeneca COVID-19: abin da kuke buƙatar sani: https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know
2) Ayyukan Mechanism na Platelets da Muhimman hanyoyin haɗin jini a cikin Hemostasis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767294/
3) Binciken COVID-19 Alurar AstraZeneca da abubuwan da suka faru na thromboembolic yana ci gaba: https://www.ema.europa.eu/en/news/investigation-covid-19-vaccine-astrazeneca-thromboembolic-events-continues
4) COVID-19 Vaccine AstraZeneca ya tabbatar da kariya 100% daga cututtuka mai tsanani, asibiti da mutuwa a cikin binciken farko na gwaji na Mataki na III: https://www.astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html
5) Bayani ga masu karɓa na Burtaniya akan rigakafin COVID 19 AstraZeneca: https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-uk-recipients-on-covid-19-vaccine-astrazeneca
Shiga tattaunawar!